3.0
Aug 23, 2012
Good coworkers, interesting projects, but strategy changes are too frequent
Current employee, more than 3 years
Boston, MA
Recommend
CEO approval
Business Outlook
Pros
Talented coworkers, interesting projects, more resources that allow looking at many aspects of drug development that might not be available at smaller companies. Most people are happy with how their own local departments are run.
Cons
There are frequent reorganizations and changes in overall strategy due to higher level turnover in leadership. One significant example is that for the last several CEOs the company has frequently changed its position on whether diversification of the company is good, or whether the company should spin off non-core units to focus on patented pharmaceuticals.
